Embryonic vs. Adult Stem Cells in Research Essay -- Argumentative Pers

Embryonic vs. Adult Stem Cells in search Why is the mainstream media significantly downplaying exciting scientific discoveries with adult stem cells? This strain hopes to adequately answer that question. Heres the scoop As originally reported modern last year in the medical journal Blood, Dr. Catherine M. Verfaillie and other researchers at the Stem Cell Institute, University of Minnesota, have discovered a way to coax cable an adult cell found in the bone marrow to possess many of the attributes that supposedly make embryonic stem cells irreplaceable to the development future miracle medical therapies(Catherine). While there is still much research to be done, multi-potent adult progenitor cells (MAPCs) appear to be versatile, that is, capable of transforming into antithetical types of tissues. (In a culture dish, the cells can be coaxed into becoming muscle, cartilage, bone, liver, or diverse types of neurons in the brain.) They are also malleable, meaning they can do so relatively easily. They also exhibit the immortality valued in embryonic cells, that is to say, they come out capable of being transformed into cell lines that can be hold indefinitely. At the same time, these adult cells do not appear to register the acute danger associated with embryonic stem cells the tendency to grow uncontrollably causing tumors or even cancers. This should be a big romance considering the intense controversy over embryonic-stem-cell research (ESCR) and the coming attempt in the United States Senate to outlaw human cloning (S.790). Indeed, the New York Times and upper-case letter Post consider embryonic-stem-cell research so important - including the manufacture and expenditure of human-clone embryos in such experiments - that both hav... ...hat the biotech researchers say more true then(prenominal) whatever cloning/ESCR opponents may argue - regardless of the actual evidence. Finally, punch in public-policy disputes usually boils down to money. Quite often, reporters dont find stories stories find reporters. That is how PR firms make the big bucks being paid quite handsomely to refreshing journalists to stories their clients want covered. In this fight, Big Biotechs very deep pockets almost stop up coverage that is skewed in favor of destroying human embryos in experiments and permitting the worldly concern of human-research clones. Sources Consulted Catherine Verfaillie http//www1.umn.edu/stemcell/sci/page/fac-mbr/verfaillie/verfaillie.shtml New Scientist http//www.newscientist.com/ New York Times http//www.nytimes.com/auth/login?URI=http//www.nytimes.com/2002/01/25/science/25STEM.html